Stocks rebounded sharply after a steep AI sector selloff, with the Nasdaq Composite gaining 3.2% as investors pivoted to tech recovery. The selloff, driven by profit-taking and concerns over AI adoption timelines, saw major players like NVIDIA and Microsoft drop over 5% on February 23. Analysts cited $100 billion in unrealized gains as a catalyst for renewed optimism, though volatility remains high.

Healthcare stocks struggled ahead of President Biden’s State of the Union address, falling 2.1% as markets priced in potential policy shifts. Elevance Health and Planet Fitness reported mixed earnings, with concerns about regulatory changes in insurance and fitness sectors weighing on valuations. Morgan Stanley noted the sector’s sensitivity to $1.2 trillion in pending legislative reforms.

Market analysts emphasized the divergence between tech and healthcare, attributing the rebound to AI’s cyclical nature and healthcare’s structural uncertainties. Saks Global highlighted the $200 billion in AI-related M&A activity this quarter, contrasting with healthcare’s stagnant deal flow. Natixis warned that interest rate cuts could further destabilize both sectors.

The close underscored a fragile equilibrium: while AI recovery signals investor confidence in long-term tech trends, healthcare’s slump reflects near-term policy risks. Bloomberg’s panel stressed that regulatory clarity and earnings momentum will dictate the next move, with Stony Brook University projecting a 6-8% rebound in AI stocks by Q2.

Key takeaways: AI stocks rebounded 3.2%, healthcare fell 2.1%, $100 billion in AI gains, $200 billion in M&A activity, $1.2 trillion in healthcare reforms, 6-8% AI rebound projection. Primary keyword: AI stock rebound. Secondary keywords: healthcare sector decline, SOTU market impact, tech volatility, regulatory changes, earnings momentum. Content type: news.